This is where mr Waggoner has been traveling this week.
He's given us a big clue by saying there will soon be more Canadians working at pharmacyte than Americans.
We know that janssen had a senior person attending our presentation at the bio convention as they reserved a place beforehand.
We know that janssen research and development has a large presence in Toronto.
With ind submission expected in the fourth quarter mr Waggoner will be looking for financing now.
We're putting this all together and given the determination of j&j to lead the diabetes space and the recent huge setbacks with viacyte a partnership with janssen for cancer and diabetes sounds like a timely and obvious fit.
And makes sense of kw's Facebook post.
I've racked my brains and can't think of any other conclusion.